Our results from this study confirmed the mRNA and protein level expression of Tim-3 in cervical cancer cell lines and revealed for the first time that Tim-3 was preferentially expressed in the clinical primary cervical cancer cells when compared to the CIN and chronic cervicitis. The gene discussed is HAVCR2; the disease is cervical cancer.